{
    "url_original": "https://www.wsj.com/articles/pfizer-to-ask-regulators-to-authorize-covid-19-vaccine-booster-11625784072?mod=business_lead_pos1",
    "url": "pfizer-to-ask-regulators-to-authorize-covid-19-vaccine-booster-11625784072",
    "title": "Pfizer to Ask Regulators to Authorize Covid-19 Vaccine Booster",
    "sub_head": "Pfizer and partner BioNTech are also developing an updated version of their vaccine that would better target the Delta variant",
    "category_1": "Business",
    "category_2": "Health Care",
    "image_1_url": "https://images.wsj.net/im-366799?width=620&size=1.5",
    "image_1": "im-366799.jpg",
    "time": "2021-07-08 18:57:00",
    "body": "Pfizer Inc.  will seek clearance from U.S. regulators in coming weeks to distribute a booster shot of its Covid-19 vaccine to heighten protection against infections as new virus strains rise.<br />The company said also it plans to start clinical trials in August of an updated version of its vaccine that would better protect against the Delta variant.<br />Pfizer and partner  BioNTech SE  said Thursday that they will seek authorization for the third shot based on encouraging initial study data.<br />The data showed, the companies said, that a booster shot given at least six months after the second dose produced antibodies protective against the original strain of the virus and a more recent strain known as Beta.<br />The companies said the antibody levels were five to 10 times higher than after two doses."
}